Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : MiUTR3H-03396
| Cat. No. | MiUTR3H-03396 |
| Description | 3'UTR clone of aldehyde dehydrogenase 3 family member B1 (ALDH3B1) transcript variant 3 for miRNA target validation |
| Gene Abbr | ALDH3B1 |
| Gene Name | ALDH3B1 aldehyde dehydrogenase 3 family, member B1 [ Homo sapiens ] |
| Species | Human |
| Reporter | luciferase-RFP |
| Promoter | SV40 |
| Resistance | Neo/Kanr |
| Selection Marker | Neomycin |
| Size | The cDNA clone is shipped in a 2-D bar-coded Matrix tube as 10 ug dried plasmid DNA. The package also includes 100 pmols of both the corresponding 5' and 3' vector primers in separate vials. |
| Vector | pMirTarget |
| Vector Type | plasmid |
| Storage | -20 ℃ |
| Gene Name | ALDH3B1 aldehyde dehydrogenase 3 family, member B1 [ Homo sapiens ] |
| Gene Symbol | ALDH3B1 |
| Synonyms | ALDH4; ALDH7 |
| Gene Description | aldehyde dehydrogenase 3 family, member B1 |
| Gene ID | 221 |
| Uni Prot ID | P43353 |
| m RNA Refseq | NM_001030010.1 |
| Protein Refseq | NP_001025181.1 |
| Chromosome Location | 11q13 |
| Function | 3-chloroallyl aldehyde dehydrogenase activity; aldehyde dehydrogenase [NAD(P)+] activity; |
| Pathway | Chemical carcinogenesis, organism-specific biosystem; Chemical carcinogenesis, conserved biosystem; Drug metabolism - cytochrome P450, organism-specific biosystem; Drug metabolism - cytochrome P450, conserved biosystem; Glycolysis / Gluconeogenesis, organism-specific biosystem; Glycolysis / Gluconeogenesis, conserved biosystem; Histidine metabolism, organism-specific biosystem; |
| MIM | 600466 |
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.